logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

Cellular Bio Acquires Rights to Solid Tumor Immunotherapy from National Cancer Institute

Oct 3, 2018

Life Science

RISE Life Science Corp (CSE:RLSC) (formerly Luminor Medical CSE: LMT)

Scott Secord Joins RISE Board of Directors as Executive Chairman

Oct 3, 2018

Life Science

5-Member GO Therapeutics Inks $195 Million Deal with Roche

Oct 2, 2018

Life Science

Kite and HiFiBiO Therapeutics Announce a Research Collaboration to Develop Technology for the Potential Discovery of Neoantigen-Reactive T Cell Receptors (TCRs) for the Treatment of Cancer

Oct 2, 2018

Life Science

CANbridge Files to Start Clinical Trials of Breast Cancer Drug in China

Oct 2, 2018

Life Science

Johnson & Johnson Completes Divestiture of LifeScan to Platinum Equity

Oct 2, 2018

Life Science

Five Prime Therapeutics and Zai Lab Dosed First Patient in Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers

Oct 2, 2018

Life Science

Dragonfly and Merck Strike $695 Million Deal for Solid Tumors

Oct 1, 2018

Life Science

Innovent Approved to Start US Clinical Trial of CD47 Immunotherapy

Oct 1, 2018

Life Science

Fosun Pharma Officially Announces Plan for Henlius IPO in Hong Kong

Oct 1, 2018

Life Science

Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry

Sep 28, 2018

Life Science

Pfizer Snags FDA Approval for New Lung Cancer Drug Vizimpro

Sep 28, 2018

Life Science

Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences

Sep 28, 2018

Life Science

Cellular Bio to Manufacture Novartis CAR-T Drug in China in $40 Million Deal

Sep 28, 2018

Life Science

F-Prime, Atlas lead cancer startup Akrevia to $30M A round

Sep 27, 2018

Life Science

Lilly Licenses Chugai Pharma’s Oral Diabetes Drug for $50 Million Upfront

Sep 27, 2018

Life Science

Evoke Acquires Navience Healthcare Solutions, LLC

Sep 27, 2018

Life Science

Bellen Chemistry of Beijing, a CRO/CMO, Raises $30 Million-Plus in C Round

Sep 27, 2018

Life Science

  • ‹‹ Previous
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada